Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$132.81 - $182.18 $1.69 Million - $2.32 Million
-12,747 Closed
0 $0
Q4 2020

Dec 01, 2022

BUY
$138.17 - $184.34 $1.76 Million - $2.35 Million
12,747 New
12,747 $2.21 Million
Q4 2020

Jan 28, 2021

SELL
$138.17 - $184.34 $606,013 - $808,515
-4,386 Reduced 25.6%
12,747 $2.21 Million
Q3 2020

Oct 29, 2020

SELL
$114.09 - $145.51 $1.15 Million - $1.46 Million
-10,065 Reduced 37.01%
17,133 $2.39 Million
Q2 2020

Jul 20, 2020

SELL
$89.45 - $129.85 $1.01 Million - $1.46 Million
-11,266 Reduced 29.29%
27,198 $3.25 Million
Q1 2020

Apr 30, 2020

BUY
$70.23 - $144.31 $2.51 Million - $5.16 Million
35,787 Added 1336.83%
38,464 $3.85 Million
Q4 2019

Feb 06, 2020

BUY
$76.41 - $117.54 $204,549 - $314,654
2,677 New
2,677 $315,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.